The European Medicines Agency (EMA) has announced it is extending its decision to hold all upcoming meetings virtually through August 2020 as a safety measure amid the ongoing coronavirus disease (COVID-19) pandemic. The EMA first made the shift to virtual-only meetings because of COVID-19 in March and extended the policy in April to continue through the end of May. Since mid-March, most EMA staff have worked remotely as well.  While many countries in Europe have taken the first steps to reopen their economies in recent weeks as new cases of COVID-19 have fallen, much of business as usual remains on hold. Learn More